Skip to main content
icon for Will Teladoc Health (TDOC) beat quarterly earnings?
Zarobki·Akcje

Will Teladoc Health (TDOC) beat quarterly earnings?

icon for Will Teladoc Health (TDOC) beat quarterly earnings?
Zarobki·Akcje

Will Teladoc Health (TDOC) beat quarterly earnings?

Jul 29

Jul 29

50% szansa
Polymarket
NOWE
50% szansa
Polymarket
NOWE
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Teladoc Health (TDOC) faces a closely balanced market-implied 50% probability of beating Q2 2026 earnings, scheduled for release after the July 29 close. Recent Q1 results showed an EPS miss at -$0.36 against consensus near -$0.32 alongside a modest revenue beat to $613.85 million, highlighting persistent profitability pressures amid softer BetterHelp volumes and elevated operating costs. Trader sentiment reflects this tension, with analysts maintaining a Hold consensus and price targets clustered near $7–10, while recent share-price gains of over 20% post-Q1 signal improving momentum. Key swing factors include potential upside in integrated care revenue or cost discipline that could exceed the projected EPS loss near -$0.24; any pre-release guidance revisions or utilization data could shift odds ahead of the report.

As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.

If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Wolumen
$0
Data zakończenia
Jul 29, 2026
Rynek otwarty
Jul 15, 2026, 8:52 PM ET

Źródło rozstrzygnięcia

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Teladoc Health (TDOC) faces a closely balanced market-implied 50% probability of beating Q2 2026 earnings, scheduled for release after the July 29 close. Recent Q1 results showed an EPS miss at -$0.36 against consensus near -$0.32 alongside a modest revenue beat to $613.85 million, highlighting persistent profitability pressures amid softer BetterHelp volumes and elevated operating costs. Trader sentiment reflects this tension, with analysts maintaining a Hold consensus and price targets clustered near $7–10, while recent share-price gains of over 20% post-Q1 signal improving momentum. Key swing factors include potential upside in integrated care revenue or cost discipline that could exceed the projected EPS loss near -$0.24; any pre-release guidance revisions or utilization data could shift odds ahead of the report.

As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.

If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Wolumen
$0
Data zakończenia
Jul 29, 2026
Rynek otwarty
Jul 15, 2026, 8:52 PM ET

Źródło rozstrzygnięcia

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Powiązane

icon for Will T-Mobile US (TMUS) beat quarterly earnings?

Will T-Mobile US (TMUS) beat quarterly earnings?

74%
icon for Will CoStar (CSGP) beat quarterly earnings?

Will CoStar (CSGP) beat quarterly earnings?

50%
icon for Will U.S. Bancorp (USB) beat quarterly earnings?

Will U.S. Bancorp (USB) beat quarterly earnings?

83%

Uważaj na linki zewnętrzne.

Często zadawane pytania

"Will Teladoc Health (TDOC) beat quarterly earnings?" to rynek prognoz na Polymarket, gdzie traderzy kupują i sprzedają udziały "Tak" lub "Nie" w zależności od tego, czy wierzą, że to wydarzenie nastąpi. Obecne zbiorowe prawdopodobieństwo to 50% na "Yes". Na przykład, jeśli "Tak" kosztuje 50¢, rynek zbiorowo przypisuje 50% szansy na to, że to wydarzenie nastąpi. Te kursy zmieniają się ciągle, gdy traderzy reagują na nowe informacje i wydarzenia. Udziały w poprawnym wyniku można wymienić na $1 za sztukę po rozstrzygnięciu rynku.

"Will Teladoc Health (TDOC) beat quarterly earnings?" to nowo utworzony rynek na Polymarket, uruchomiony Jul 15, 2026. Jako wczesny rynek, to Twoja okazja, aby być jednym z pierwszych traderów, którzy ustalą kursy i określą początkowe sygnały cenowe rynku. Możesz też dodać tę stronę do zakładek, aby śledzić wolumen i aktywność handlową w miarę rozwoju rynku.

Aby handlować na "Will Teladoc Health (TDOC) beat quarterly earnings?", wybierz, czy uważasz, że odpowiedź to "Tak" czy "Nie". Każda strona ma bieżącą cenę odzwierciedlającą implikowane prawdopodobieństwo rynku. Wpisz kwotę i kliknij "Handluj". Jeśli kupisz udziały "Tak" i wynik okaże się "Tak", każdy udział wypłaci $1. Jeśli okaże się "Nie", Twoje udziały "Tak" wypłacą $0. Możesz też sprzedać swoje udziały w dowolnym momencie przed rozstrzygnięciem, jeśli chcesz zrealizować zysk lub ograniczyć stratę.

Obecne prawdopodobieństwo dla "Will Teladoc Health (TDOC) beat quarterly earnings?" to 50% na "Yes". Oznacza to, że społeczność Polymarket uważa, że istnieje 50% szansy na to, że to wydarzenie nastąpi. Te kursy aktualizują się w czasie rzeczywistym na podstawie rzeczywistych transakcji, dostarczając ciągle aktualizowany sygnał tego, czego rynek oczekuje.

Zasady rozstrzygania "Will Teladoc Health (TDOC) beat quarterly earnings?" określają dokładnie, co musi się wydarzyć, aby każdy wynik został ogłoszony zwycięzcą — w tym oficjalne źródła danych używane do ustalenia wyniku. Możesz przejrzeć pełne kryteria rozstrzygania w sekcji "Zasady" na tej stronie nad komentarzami. Zalecamy dokładne zapoznanie się z zasadami przed handlem, ponieważ określają one precyzyjne warunki, przypadki graniczne i źródła regulujące rozstrzyganie tego rynku.